Caplin Point Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

2311.45

-82.15 (-3.43%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

2311.45

-82.15 (-3.43%)
16:02 Dec 20

Quality

50/100
Medium Financial Strength

Valuation

27/100
Expensive Valuation

Technical

64/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	1061.29	1269.41	1466.73	1694.1	1830.78
Operating Expenses +	732.65	874.74	1025.67	1142.66	1226.7
Raw Material	389.39	589.43	710.15	798.73	740.06
Increase Decrease in Cost	82.35	-31.92	-46.94	-74.55	15.72
Other Manufacturing Expense	3.36	0	0	0	0
Employee Cost	102.53	115.3	136.99	143.59	157.88
Miscellaneous Expenses	674.16	996.17	1233.21	1392.73	313.04
Operating Profit	328.64	394.67	441.06	551.44	604.08
Other Income	23.54	38.75	55.98	66.94	73.8
Depreciation	36.97	46.9	44.99	53.44	63.02
Interest	1.59	0.7	0.78	0.78	0.58
Profit before tax and exceptio..	313.62	385.82	451.27	564.16	614.28
Exceptional Items	0	0	0.08	0.27	0
PBT	313.62	385.82	451.35	564.43	614.28
Provision for Taxation	62.19	77.37	74.36	103.01	117.5
Net Profit	251.43	308.45	376.99	461.42	496.78
NET Profit after MI	242.27	299.84	376.26	457.09	493.56
EPS	31.71	39.61	49.18	60.19	64.99
Operating Profit Margin (%)	30.97	31.09	30.07	32.55	33
Net Profit Margin (%)	22.83	23.62	25.65	26.98	26.96

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	70.60	70.60	70.60	70.60	70.60
FII	3.70	3.40	3.30	2.80	3.10
MF	1.60	1.30	1.10	0.40	0.00
Public	23.90	24.60	25.00	26.10	26.10
Others	0.00	0.00	0.00	0.00	0.00
Others	0.20	0.10	0.00	0.10	0.20